Leading Global Pharmaceutical Selects MACS to upgrade their IBM Maximo across Europe

/, Press Release/Leading Global Pharmaceutical Selects MACS to upgrade their IBM Maximo across Europe

Leading Global Pharmaceutical Selects MACS to upgrade their IBM Maximo across Europe

Uxbridge, 28 October 2014: A leading international pharmaceutical has awarded MACS to lead the upgrade implementation of their IBM Maximo Asset Management with calibration. The implementation will support to standardise the business practices across the pharmaceutical’s plants in Norway, Ireland and United Kingdom. MACS will also implement IBM Scheduler as part of the upgrade project. The contract was awarded after a selection process led by the pharmaceutical.

“In recent years we have seen significant business growth in the Life Science Industry.”, said Guus De Nijs, Managing Director MACS. “MACS has created a centre of excellence around the pharmaceutical industry which benefits our clients by reducing the risk of non-compliance, rationalise their calibration management processes, improve reporting capabilities and general cost reduction. MACS is proud of being a trusted business advisor to its clients”.

MACS’ experience in handling pharmaceutical specific compliance challenges, including Validation, along with an extensive history of IBM Maximo implementation reduces the project risk and potential project over runs. MACS provides IBM Maximo Asset Management services to five leading pharmaceutical organisations across Europe.

The MACS Holding company, established in 1998, employs staff in Netherlands, Belgium, Germany and United Kingdom. MACS provides professional services with a broad experience of implementing solutions for Maintenance Management, Asset Management and IT Service Management. A long standing premier IBM Business Partner distributing IBM Maximo Asset Management and IBM Tririga software across the regional offices.

IBM Maximo Asset Management is a world renowned software product. The IBM Maximo Enterprise Asset Management solution unifies comprehensive asset life cycle and maintenance management on a single platform, providing insight into all of an organization’s enterprise assets, their conditions and work processes to achieve better planning and control. IBM Maximo also includes specific industries solutions such as for the Life Science industry.

More information can be found at www.macseu.co.uk

By | 2018-03-09T06:51:51+00:00 November 6th, 2014|News, Press Release|Comments Off on Leading Global Pharmaceutical Selects MACS to upgrade their IBM Maximo across Europe

About the Author:

%d bloggers like this: